Healthcare -
Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 153.27
-0.013 %
$ 15.5 B
Market Cap
40.87
P/E
NBIX - CASH FROM FINANCING ACTIVITIES
Cash from Financing Activities NBIX - Neurocrine Biosciences, Inc.
65.3 M
LAST VALUE
54.38%
2 YEAR CAGR
17.20%
5 YEAR CAGR
28.54%
10 YEAR CAGR